Cargando…
PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers
To date, immune check-point inhibitors (ICIs), particularly inhibitors of programmed cell death-1 (PD-1) and PD ligand-1 (PD-L1) have become prominent in cancer treatment and also improved life expectancy of cancer patients. As key regulators of PD-1/PD-L1 axis, the recruitment of tumor-associated m...
Autores principales: | Wu, Tiantian, Tang, Caijin, Tao, Renchuan, Yong, Xiangzhi, Jiang, Qiaozhi, Feng, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450501/ https://www.ncbi.nlm.nih.gov/pubmed/34552581 http://dx.doi.org/10.3389/fimmu.2021.693881 |
Ejemplares similares
-
Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma
por: COSTA, Liana Cristina Melo Carneiro, et al.
Publicado: (2015) -
Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
por: Krisanaprakornkit, Suttichai, et al.
Publicado: (2012) -
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016) -
MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2021) -
Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma
por: Hu, Yong, et al.
Publicado: (2016)